1190003K10Rik Activators encompass a diverse array of chemical compounds that elevate the activity of the 1190003K10Rik protein through various intracellular signaling pathways. Forskolin, IBMX, Rolipram, PGE2, Isoproterenol, and Anagrelide all function to increase intracellular cAMP levels, albeit through different mechanisms: Forskolin by directly activating adenylyl cyclase, IBMX and Rolipram by inhibiting phosphodiesterases that degrade cAMP, PGE2 through its receptor-mediated action, Isoproterenol by acting on beta-adrenergic receptors, and Anagrelide by specifically inhibiting PDE3. This rise in cAMP levels is a pivotal step that activates protein kinase A (PKA), which is known to phosphorylate a myriad of proteins, potentially creating a conducive environment for 1190003K10Rik activation. Similarly, Zaprinast and Sildenafil, by inhibiting PDE5, along with YC-1 that also stimulates soluble guanylyl cyclase, all raise cGMP levels,which subsequently could influence the signaling cascades that include 1190003K10Rik, thus enhancing its functional activity through cGMP-dependent protein kinases or other cGMP-responsive elements.
Calcium signaling is another crucial modulator for numerous proteins, and in the case of 1190003K10Rik, compounds like A23187 and Ionomycin play a significant role by increasing the intracellular calcium concentration. This elevation in calcium ions can activate calcium-dependent protein kinases, which are capable of altering the activity of numerous proteins and signaling pathways. By doing so, these ionophores indirectly facilitate the enhancement of 1190003K10Rik's functional activity by ensuring that calcium-dependent signaling pathways are robustly stimulated. L-Arginine also contributes to the activation of 1190003K10Rik through its role as a substrate for nitric oxide synthase, leading to the production of nitric oxide that activates guanylyl cyclase. The resultant increase in cGMP can have similar effects as those of the PDE5 inhibitors, potentially creating conditions favorable for the activation of 1190003K10Rik. Collectively, these activators work in concert through their targeted biochemical actions to enhance the functional activity of 1190003K10Rik without the need for upregulation of its expression or direct binding and activation, ensuring that the protein's activity is modulated in a context-dependent manner.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which increases intracellular cAMP by preventing its breakdown, thereby enhancing pathways that lead to activation of 1190003K10Rik. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram selectively inhibits PDE4, leading to increased cAMP levels, which can promote the activation of signaling cascades that 1190003K10Rik is involved in. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Prostaglandin E2 (PGE2) activates its G-protein-coupled receptors that can lead to an increase in cAMP, thus potentially enhancing the signaling pathways that activate 1190003K10Rik. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $30.00 $60.00 $215.00 $345.00 | 2 | |
L-Arginine is a substrate for nitric oxide synthase, and the nitric oxide produced can modulate signaling pathways by activating guanylyl cyclase to increase cGMP, which in turn can enhance the activity of 1190003K10Rik. | ||||||
YC-1 | 170632-47-0 | sc-202856 sc-202856A sc-202856B sc-202856C | 1 mg 5 mg 10 mg 50 mg | $32.00 $122.00 $214.00 $928.00 | 9 | |
YC-1 enhances cGMP levels by inhibiting PDE5 and stimulating soluble guanylyl cyclase, thereby enhancing the signaling pathways in which 1190003K10Rik is involved. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium concentration, which can activate calcium-dependent signaling pathways and indirectly enhance the functional activity of 1190003K10Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular Ca2+ levels, potentially activating Ca2+-dependent protein kinases that enhance signaling pathways involving 1190003K10Rik. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Zaprinast inhibits PDE5 and PDE10, leading to an increase in cGMP levels, which may indirectly enhance the activation of pathways that involve 1190003K10Rik. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $147.00 | ||
Anagrelide inhibits PDE3, resulting in increased cAMP levels, which could lead to the activation of signaling pathways that 1190003K10Rik is part of. |